A 2025 regulatory analysis by Hurley and Frier at Frier Levitt outlined the practical implications: legitimate medical access to many peptides continues, but the sourcing pathway matters more than ever, and the clinician's knowledge of the current regulatory status of each specific compound is a prerequisite for appropriate prescribing
Several CMS policy and payment changes directly affect how this code is reimbursed and billed, and your billing system needs to reflect each one
Supplementing with B12 shots ensures they receive adequate amounts without compromising their dietary choices
For others, it takes a couple of injections
Collagen Production Goes Into Overdrive The headline number is a 70% increase in collagen I production in human dermal fibroblasts at optimal concentrations
BPC-157 is a compounded peptide that is not FDA-approved for the indications described and is not marketed to treat, cure, prevent, or diagnose any disease